Leaflet IMMUNOHBS 180UI / 1ml solution for injection


Indicated for: chronic hepatitis B

Route of administration: injectable

Substance: human anti-hepatitis B immunoglobulin (immunoglobulin)

ATC: J06BB04 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Human anti-hepatitis B immunoglobulin is a plasma-derived product used to prevent hepatitis B virus (HBV) infection, particularly in individuals recently exposed to the virus or those at high risk, such as newborns of infected mothers. It provides passive immunity by supplying specific antibodies against HBV.

The medication is administered via intramuscular or intravenous injection, as directed by a doctor.

Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about IMMUNOHBS 180UI / 1ml

  • Substance: human anti-hepatitis B immunoglobulin
  • Date of last drug list: 01-11-2023
  • Commercial code: W69359001
  • Concentration: 180UI / 1ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: KEDRION S.P.A. - ITALIA
  • Holder: BESMAX PHARMA SOLUTIONS S.R.L. - ROMANIA
  • Number: 2/2022/01
  • Shelf life: 3 years;after the first opening-se administreaza imediat

Pharmaceutical forms available for human anti-hepatitis B immunoglobulin

Concentrations available for human anti-hepatitis B immunoglobulin

  • 1000UI/3ml
  • 180UI/1ml
  • 500UI
  • 50UI/ml
  • 540UI/3ml